Bojan Losic

4.0k total citations · 1 hit paper
13 papers, 901 citations indexed

About

Bojan Losic is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bojan Losic has authored 13 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Bojan Losic's work include Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Bojan Losic is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Bojan Losic collaborates with scholars based in United States, Spain and Germany. Bojan Losic's co-authors include Augusto Villanueva, Josep M. Llovet, Manel Esteller, Vincenzo Mazzaferro, Nicholas K. Akers, Daniela Sia, Carlos Villacorta-Martín, Swan N. Thung, Juan Putra and Samuel Waxman and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and Gastroenterology.

In The Last Decade

Bojan Losic

13 papers receiving 896 citations

Hit Papers

Identification of an Immune-specific Class of Hepatocellu... 2017 2026 2020 2023 2017 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bojan Losic United States 8 381 356 298 278 262 13 901
Longzi Liu China 11 311 0.8× 111 0.3× 436 1.5× 337 1.2× 148 0.6× 12 878
Emanuela Balladore Italy 8 405 1.1× 160 0.4× 272 0.9× 132 0.5× 67 0.3× 14 771
Chu‐Bin Luo China 15 295 0.8× 102 0.3× 510 1.7× 451 1.6× 132 0.5× 26 972
Christine To Canada 9 323 0.8× 116 0.3× 391 1.3× 196 0.7× 173 0.7× 11 708
Su-Su Zheng China 14 284 0.7× 81 0.2× 304 1.0× 253 0.9× 180 0.7× 30 746
Lei‐Bo Xu China 17 192 0.5× 141 0.4× 435 1.5× 344 1.2× 93 0.4× 38 783
Linquan Wu China 15 167 0.4× 73 0.2× 460 1.5× 311 1.1× 144 0.5× 34 714
Jincai Wu China 12 138 0.4× 106 0.3× 309 1.0× 185 0.7× 126 0.5× 29 566
Di‐Peng Ou China 11 137 0.4× 268 0.8× 279 0.9× 182 0.7× 62 0.2× 14 628
Rongfa Yuan China 19 337 0.9× 51 0.1× 559 1.9× 241 0.9× 217 0.8× 44 962

Countries citing papers authored by Bojan Losic

Since Specialization
Citations

This map shows the geographic impact of Bojan Losic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojan Losic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojan Losic more than expected).

Fields of papers citing papers by Bojan Losic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojan Losic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojan Losic. The network helps show where Bojan Losic may publish in the future.

Co-authorship network of co-authors of Bojan Losic

This figure shows the co-authorship network connecting the top 25 collaborators of Bojan Losic. A scholar is included among the top collaborators of Bojan Losic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojan Losic. Bojan Losic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bozkus, Cansu Cimen, Julia Kodysh, Simon K. Cheng, et al.. (2024). CTIM-10. PHASE 1 TRIAL OF PERSONALIZED NEOANTIGEN VACCINES IN COMBINATION WITH STANDARD CARE TO TREAT GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii86–viii87. 1 indexed citations
2.
Peters, Lauren, Joshua R. Friedman, Aleksandar Stojmirović, et al.. (2023). A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients. Communications Biology. 6(1). 95–95. 4 indexed citations
3.
Alexander, Roger P., Robert R. Kitchen, Juan Pablo Tosar, et al.. (2022). Open Problems in Extracellular RNA Data Analysis: Insights From an ERCC Online Workshop. Frontiers in Genetics. 12. 778416–778416. 3 indexed citations
4.
Craig, Amanda J., Teresa García‐Lezana, Marina Ruiz de Galarreta, et al.. (2021). Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS Genetics. 17(6). e1009589–e1009589. 16 indexed citations
5.
Felden, Johann von, Teresa García‐Lezana, Kornelius Schulze, Bojan Losic, & Augusto Villanueva. (2020). Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut. 69(11). 2025–2034. 81 indexed citations
6.
Hernandez‐Meza, Gabriela, Johann von Felden, Edgar Gonzalez‐Kozlova, et al.. (2020). DNA Methylation Profiling of Human Hepatocarcinogenesis. Hepatology. 74(1). 183–199. 71 indexed citations
7.
Sia, Daniela, Yang Jiao, Iris Martinez-Quetglas, et al.. (2017). Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. Gastroenterology. 153(3). 812–826. 632 indexed citations breakdown →
8.
Galsky, Matt D., Andrew Uzilov, Russell B. McBride, et al.. (2017). DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC).. Journal of Clinical Oncology. 35(6_suppl). 300–300. 8 indexed citations
9.
Chen, Xintong, Sander M. Houten, Kimaada Allette, et al.. (2017). Characterization of drug-induced splicing complexity in prostate cancer cell line using long read technology. PubMed. 23. 8–19. 4 indexed citations
10.
Scarpa, Joseph R., Peng Jiang, Bojan Losic, et al.. (2016). Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington’s Disease. PLoS Genetics. 12(7). e1006137–e1006137. 21 indexed citations
11.
Martignetti, John A., Olga Camacho‐Vanegas, Nolan Priedigkeit, et al.. (2014). Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA. Neoplasia. 16(1). 97–W29. 46 indexed citations
12.
Sia, Daniela, Bojan Losic, Laia Cabellos, et al.. (2014). O100 DISCOVERY OF NOVEL MUTATIONS AND FUSION PROTEINS IN INTRAHEPATIC CHOLANGIOCARCINOMA. Journal of Hepatology. 60(1). S41–S41. 2 indexed citations
13.
Holt, Carson, Bojan Losic, Deepa Pai, et al.. (2013). WaveCNV: allele-specific copy number alterations in primary tumors and xenograft models from next-generation sequencing. Bioinformatics. 30(6). 768–774. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026